EVOTEC SEINH O.N. news, videos and press releases - Page 8
For more news please use our advanced search feature.
EVOTEC SEINH O.N. - More news...
EVOTEC SEINH O.N. - More news...
- DGAP-News: Evotec achieves programme designation in neuroscience collaboration with Bristol Myers Squibb
- Evotec Achieves Programme Designation in Neuroscience Collaboration with Bristol Myers Squibb
- DGAP-News: Evotec SE to announce results for fiscal year 2021 on 12 April 2022
- Evotec SE to Announce Results for Fiscal Year 2021 on 12 April 2022
- DGAP-News: Evotec receives € 3 m milestone payment for Bayer starting Phase II clinical development of DNP programme
- Evotec Receives € 3 m Milestone Payment for Bayer Starting Phase II Clinical Development of DNP Programme
- DGAP-News: Evotec presents strategic roadmap towards precision medicine and confirms goals of Action Plan 2025 at Capital Markets Day
- Evotec Presents Strategic Roadmap Towards Precision Medicine and Confirms Goals of Action Plan 2025 at Capital Markets Day
- DGAP-News: Evotec expands molecular patient database with unique nephrotic syndrome cohort from the University of Bristol
- Evotec Expands Molecular Patient Database with Unique Nephrotic Syndrome Cohort from the University of Bristol
- DGAP-Adhoc: Evotec SE: Bayer discontinues clinical development candidate eliapixant (BAY1817080), Evotec regains the rights to all P2X3 assets
- Bayer Discontinues Clinical Development Candidate Eliapixant (BAY1817080), Evotec Regains the Rights to all P2X3 Assets
- DGAP-News: Evotec enters iPSC-based drug discovery partnership with Boehringer Ingelheim in ophthalmology
- Evotec Enters iPSC-based Drug Discovery Partnership with Boehringer Ingelheim in Ophthalmology
- DGAP-News: Evotec and Lilly enter into drug discovery collaboration in metabolic diseases
- Evotec and Lilly Enter into Drug Discovery Collaboration in Metabolic Diseases
- DGAP-News: Evotec expands neuroscience collaboration with Bristol Myers Squibb to include new targeted protein degradation approach
- Evotec Expands Neuroscience Collaboration with Bristol Myers Squibb to Include New Targeted Protein Degradation Approach
- DGAP-News: Evotec receives € 7.5 m grant for development of COVID-19 therapeutic
- Evotec Receives € 7.5 m Grant for Development of COVID-19 Therapeutic
- DGAP-News: Evotec receives US$ 18 m grant for women's health
- Evotec Receives US$ 18 M Grant for Women's Health
- DGAP-News: Evotec and EQRx announce integrated drug discovery and development partnership
- Evotec and EQRx Announce Integrated Drug Discovery and Development Partnership
- DGAP-News: Evotec SE reports results for the first nine months 2021 and provides corporate update
- Evotec SE Reports Results for the First Nine Months 2021 and Provides Corporate Update
- DGAP-News: Evotec reaches programme designations in neuroscience collaboration with Bristol Myers Squibb
- Evotec Reaches Programme Designations in Neuroscience Collaboration with Bristol Myers Squibb
- DGAP-News: Evotec SE announces closing of public offering
- Evotec SE Announces Closing of Public Offering
